Avenue Market Cap from 2010 to 2025

ATXIDelisted Stock  USD 0.36  0.02  5.26%   
Check Avenue Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avenue Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Avenue financial statements analysis is a perfect complement when working with Avenue Therapeutics Valuation or Volatility modules.
  
This module can also supplement various Avenue Therapeutics Technical models . Check out the analysis of Avenue Therapeutics Correlation against competitors.

About Avenue Therapeutics Financial Statements

Investors use fundamental indicators, such as Avenue Therapeutics' Market Cap, to determine how well the company is positioned to perform in the future. Although Avenue Therapeutics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acuteintensive care hospital setting. The company was incorporated in 2015 and is based in New York, New York. Avenue Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.

Currently Active Assets on Macroaxis

Check out the analysis of Avenue Therapeutics Correlation against competitors.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in Avenue Pink Sheet

If you are still planning to invest in Avenue Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Avenue Therapeutics' history and understand the potential risks before investing.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Transaction History
View history of all your transactions and understand their impact on performance